ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,304.80
      0.00%
      Dow Jones
      40,421.36
      0.33%
      Brent Oil
      81.755
      0.29%
      Bitcoin
      66,590.46
      -1.50%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Pieris Pharmaceuticals Inc (PIRS)

      7. Pieris Pharmaceuticals Inc (PIRS) Financials

      Pieris Pharmaceuticals Inc

      Pieris Pharmaceuticals Inc (PIRS)

      NASDAQ
      7.4815
      0.00
      (0.00%)
      Closed July 23 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Pieris Pharmaceuticals Inc Financial Summary

      The current PIRS market cap is 9.88M. The company's latest EPS is USD -18.5898 and P/E is -0.40.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.94M20.06M19.52M1.3M53k
      Operating Income -15.51M2.06M3.09M-5.48M-5.3M
      Net Income -13.18M3.98M-10.75M-4.58M-4.89M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 46.28M29.32M31.42M25.9M42.81M
      Operating Income -27.16M-33.92M-51.83M-43.47M-15.84M
      Net Income -25.47M-37.23M-45.74M-33.28M-24.54M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 82.26M87.54M59.38M38.68M29.5M
      Total Liabilities 66.8M47.05M28.87M11.92M7.53M
      Total Equity 15.46M40.5M30.51M26.76M21.96M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 141.1M105.01M153.56M95.49M38.68M
      Total Liabilities 89.75M73.98M102.81M67.56M11.92M
      Total Equity 51.35M31.03M50.76M27.93M26.76M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -11M-24.43M-34.15M-53.82M-7M
      Investing 11.9M10.54M8.55M12M9M
      Financing N/A 19.78M19.78M19.8M N/A
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -52.47M-45.9M-7.66M-59.93M-53.82M
      Investing 9.84M39.21M-949k-21.24M12M
      Financing 32.17M10.12M59.13M7.21M19.8M

      Stats and Ratios

      Market Cap 9.88M
      Price to Earnings Ratio -0.40
      Price to Sales Ratio 0.23
      Price to Cash Ratio 0.57
      Price to Book Ratio 0.37
      Dividend Yield -

      Share Statistics

      Shares Outstanding 1.32M
      Average Volume (1 week) 26.94k
      Average Volume (1 Month) 39.31k
      52 Week Change -57.89%
      52 Week High 41.784
      52 Week Low 6.20
      Spread (Intraday) 3.31 (42.38%)

      Company Info

      Company Name Pieris Pharmaceuticals Inc
      Address 3773 howard hughes pkwy
      las vegas, nevada 89169
      Website https://www.pieris.com
      Industry coml physical, biologcl resh (8731)